FRA:CBHD - Deutsche Boerse Ag - DK0060448595 - Common Stock - Currency: EUR
FRA:CBHD (3/7/2025, 7:00:00 PM)
99.9
-0.3 (-0.3%)
The current stock price of CBHD.DE is 99.9 EUR. In the past month the price decreased by -4.86%. In the past year, price decreased by -22.98%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EL.PA | ESSILORLUXOTTICA | 53.13 | 124.44B | ||
ESL.DE | ESSILORLUXOTTICA | 53.09 | 124.35B | ||
1EL.MI | ESSILORLUXOTTICA | 52.97 | 124.08B | ||
GENT.OL | GENTIAN DIAGNOSTICS ASA | 16.31 | 721.66M | ||
GBT.PA | GUERBET | 10.23 | 341.28M | ||
ALCJ.PA | CROSSJECT | N/A | 91.07M | ||
PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 89.03M | ||
AFME.PA | AFFLUENT MEDICAL SA | N/A | 55.09M | ||
SVS.MI | SVAS BIOSANA SPA | 7.25 | 41.44M | ||
IVN.MI | IVISION TECH SPA | N/A | 16.85M |
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
COLOPLAST-B
Holtedam 1-3
Humlebaek DK
Employees: 16019
Company Website: https://www.coloplast.dk/
Investor Relations: https://investor.coloplast.com
Phone: 4549111111
The current stock price of CBHD.DE is 99.9 EUR. The price decreased by -0.3% in the last trading session.
The exchange symbol of COLOPLAST-B is CBHD and it is listed on the Deutsche Boerse Ag exchange.
CBHD.DE stock is listed on the Deutsche Boerse Ag exchange.
28 analysts have analysed CBHD.DE and the average price target is 126.79 EUR. This implies a price increase of 26.91% is expected in the next year compared to the current price of 99.9. Check the COLOPLAST-B stock analysts ratings, price target forecast and up-and down grades for more detailed information.
COLOPLAST-B (CBHD.DE) has a market capitalization of 21.00B EUR. This makes CBHD.DE a Large Cap stock.
COLOPLAST-B (CBHD.DE) currently has 16019 employees.
COLOPLAST-B (CBHD.DE) has a support level at 99.89 and a resistance level at 103.53. Check the full technical report for a detailed analysis of CBHD.DE support and resistance levels.
The Revenue of COLOPLAST-B (CBHD.DE) is expected to grow by 7.47% in the next year. Check the estimates tab for more information on the CBHD.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
COLOPLAST-B (CBHD.DE) has a dividend yield of 2.98%. The yearly dividend amount is currently 2.81. Check the full fundamental report for a detailed analysis of CBHD.DE dividend history, reliability and sustainability.
COLOPLAST-B (CBHD.DE) will report earnings on 2025-05-06.
The PE ratio for COLOPLAST-B (CBHD.DE) is 33.98. This is based on the reported non-GAAP earnings per share of 2.94 and the current share price of 99.9 EUR. Check the full fundamental report for a full analysis of the valuation metrics for CBHD.DE.
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE. CBHD.DE has an excellent profitability rating, but there are concerns on its financial health.
Over the last trailing twelve months CBHD.DE reported a non-GAAP Earnings per Share(EPS) of 2.94. The EPS decreased by -1.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.69% | ||
ROA | 10.51% | ||
ROE | 28.16% | ||
Debt/Equity | 0.96 |
ChartMill assigns a Buy % Consensus number of 69% to CBHD.DE. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 14.15% and a revenue growth 7.47% for CBHD.DE